Skip to main content
    A

    Adlai Nortye Ltd. American Depositary Shares (ANL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.03
    -0.58 (-5.47%)

    Market Cap: $683.26M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Adlai Nortye Ltd. American Depositary Shares (ANL) Financials: Revenue, Profit and Cash Flow

    Updated Aug 14, 2026. Financial statements from company filings, amounts in US dollars.

    Adlai Nortye Ltd. American Depositary Shares reported revenue of $5.00M for the fiscal year ended Dec 31, 2025. That year, net income was -$35.53M with a net margin of -710.6%, operating cash flow was -$33.54M and free cash flow was -$33.73M. The quarter ended Jun 30, 2026 had revenue of $7.34M and net income of -$2.67M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$5.00MN/A100.0%-714.0%-710.6%
    Dec 2024$0-100.0%N/AN/AN/A
    Dec 2023$5.00MN/A100.1%-1452.3%-2186.5%
    Dec 2022$0-100.0%N/AN/AN/A
    Dec 2021$45.73MN/A100.0%-18.9%-124.0%
    Dec 2020N/AN/AN/AN/AN/A
    Dec 2019N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$5.00M$0$5.00M$0$45.73MN/AN/A
    Cost of revenueN/A$1.87M$2.22M$2.04MN/A$1.51M$1.48M
    Gross profit$5.00M-$1.87M$5.00M-$2.04M$45.73M-$1.51M-$1.48M
    Research and development$32.83M$44.91M$58.15M$54.49M$42.10M$19.04M$13.34M
    Operating income-$35.70M-$52.93M-$72.55M-$67.27M-$8.65M-$26.10M-$19.12M
    Net income-$35.53M-$51.87M-$109.23M-$58.79M-$56.68M-$63.38M-$17.83M
    EBITDA-$32.63M-$48.05MN/A-$56.32MN/AN/A-$15.88M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Revenue$7.34M$7.34M$2.50M$2.50MN/AN/AN/A$745.00K$745.00K$2.50M$2.50M$0
    Gross profit$7.34M$7.34M$2.50M$2.50MN/AN/AN/A$745.00K$745.00K$2.50M$2.50M-$646.00K
    Operating income-$2.88M-$2.88M-$8.26M-$8.26M-$9.59M-$9.59M-$11.84M-$14.62M-$14.62M-$17.71M-$20.21M-$16.86M
    Net income-$2.67M-$2.67M-$8.60M-$8.60M-$9.17M-$9.17M-$12.13M-$13.81M-$13.81M-$13.23M-$15.40M-$63.40M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, short-term debt of $25.25M exceeded cash and equivalents by $1.46M. Shareholder equity was negative, at -$8.32M, as total liabilities of $42.76M exceeded total assets of $34.43M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$34.43M$71.27M$130.19M$72.59M$131.69M$36.74M$10.80M
    Current assets$26.89M$64.06M$101.19M$66.30M$124.54M$28.59M$6.43M
    Cash and equivalents$23.79M$60.90M$91.49M$42.76M$64.13M$24.21M$6.02M
    Total liabilities$42.76M$45.78M$55.14M$313.89M$317.11M$168.30M$80.18M
    Short-term debt$25.25M$26.80M$31.08M$5.31M$11.29M$9.08M$10.92M
    Shareholder equity-$8.32M$25.48M$75.05M-$241.29M-$185.43M-$131.56M-$69.38M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$248.36M$248.36M$34.43M$34.43M$72.05M$72.05M$71.27M$71.27M$107.68M$107.68M$130.19M$130.19M
    Total liabilities$33.53M$33.53M$42.76M$42.75M$64.12M$64.12M$45.78M$45.78M$54.31M$54.31M$50.79M$55.14M
    Cash and equivalents$132.59M$132.59M$8.06M$8.06M$44.14M$44.14M$60.90M$60.90M$97.98M$97.98M$91.49M$91.49M
    Shareholder equity$214.83M$214.83M-$8.32M-$8.32M$7.92M$7.92M$25.48M$25.48M$53.37M$53.37M$79.40M$75.05M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$33.54M-$51.82M-$56.65M-$43.22M-$3.03M-$34.59M-$14.92M
    Capital expenditures$187.49K$170.00K$200.00K$1.27M$1.12M$1.62M$184.95K
    Free cash flow-$33.73M-$51.99M-$56.85M-$44.49M-$4.15M-$36.22M-$15.11M
    Investing cash flow-$15.62M$28.07M-$10.95M$28.38M-$54.86M-$1.61M-$184.52K
    Financing cash flow-$3.82M-$6.58M$116.24M-$6.78M$97.20M$53.89M$16.22M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Operating cash flow-$7.68M-$7.68M-$9.17M-$9.17M-$7.56M-$7.56M-$11.72M-$14.19M-$14.19M-$19.16M-$19.16M-$8.32M
    Capital expenditures$0$187.00K$93.50K$93.50K$0$85.00K$85.00K$61.00K$61.00K$57.50K$57.50K$63.00K
    Free cash flow-$7.68M-$7.86M-$9.26M-$9.26M-$7.56M-$7.65M-$11.81M-$14.25M-$14.25M-$19.22M-$19.22M-$8.38M
    Last 12 quarters

    Frequently Asked Questions About ANL

    What is Adlai Nortye Ltd. American Depositary Shares' annual revenue?

    Adlai Nortye Ltd. American Depositary Shares reported revenue of $5.00M for the fiscal year ended Dec 31, 2025.

    Is Adlai Nortye Ltd. American Depositary Shares profitable?

    No. Adlai Nortye Ltd. American Depositary Shares reported net income of -$35.53M for the fiscal year ended Dec 31, 2025, with a net margin of -710.6%.

    How much free cash flow does ANL generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$33.54M minus capital expenditures of $187.49K produced free cash flow of -$33.73M.

    How much debt does Adlai Nortye Ltd. American Depositary Shares have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $25.25M and cash and equivalents of $23.79M.

    What is ANL's profit margin?

    For the fiscal year ended Dec 31, 2025, Adlai Nortye Ltd. American Depositary Shares reported gross margin of 100.0%, operating margin of -714.0% and net margin of -710.6%.